EU asks industry for comment on clarity of pricing/reimbursement decisions
This article was originally published in Scrip
Executive Summary
The European Commission has launched a public consultation on how to improve the transparency of pharmaceutical pricing and reimbursement decisions by member states under the current EU rules.